vs
Side-by-side financial comparison of Xiao-I Corp (AIXI) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.
Xiao-I Corp is the larger business by last-quarter revenue ($11.5M vs $9.2M, roughly 1.2× Cytosorbents Corp). Cytosorbents Corp runs the higher net margin — -59.5% vs -263.9%, a 204.3% gap on every dollar of revenue.
Xiao-i is a Chinese cognitive artificial intelligence enterprise founded in 2001.
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
AIXI vs CTSO — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.5M | $9.2M |
| Net Profit | $-30.4M | $-5.5M |
| Gross Margin | 58.1% | 73.7% |
| Operating Margin | -254.9% | -47.5% |
| Net Margin | -263.9% | -59.5% |
| Revenue YoY | — | 0.9% |
| Net Profit YoY | — | 27.4% |
| EPS (diluted) | — | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $9.2M | ||
| Q3 25 | — | $9.5M | ||
| Q2 25 | $11.5M | $9.6M | ||
| Q1 25 | — | $8.7M | ||
| Q4 24 | — | $9.2M | ||
| Q3 24 | — | $8.6M | ||
| Q2 24 | $33.0M | $8.8M | ||
| Q1 24 | — | $9.0M |
| Q4 25 | — | $-5.5M | ||
| Q3 25 | — | $-3.2M | ||
| Q2 25 | $-30.4M | $1.9M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | — | $-7.6M | ||
| Q3 24 | — | $-2.8M | ||
| Q2 24 | $-15.5M | $-4.3M | ||
| Q1 24 | — | $-6.1M |
| Q4 25 | — | 73.7% | ||
| Q3 25 | — | 70.3% | ||
| Q2 25 | 58.1% | 70.9% | ||
| Q1 25 | — | 71.1% | ||
| Q4 24 | — | 68.4% | ||
| Q3 24 | — | 61.0% | ||
| Q2 24 | 64.5% | 73.5% | ||
| Q1 24 | — | 76.5% |
| Q4 25 | — | -47.5% | ||
| Q3 25 | — | -30.2% | ||
| Q2 25 | -254.9% | -37.6% | ||
| Q1 25 | — | -44.5% | ||
| Q4 24 | — | -37.1% | ||
| Q3 24 | — | -56.1% | ||
| Q2 24 | -45.0% | -40.4% | ||
| Q1 24 | — | -51.8% |
| Q4 25 | — | -59.5% | ||
| Q3 25 | — | -33.4% | ||
| Q2 25 | -263.9% | 20.2% | ||
| Q1 25 | — | -16.9% | ||
| Q4 24 | — | -82.7% | ||
| Q3 24 | — | -32.1% | ||
| Q2 24 | -47.2% | -48.6% | ||
| Q1 24 | — | -67.7% |
| Q4 25 | — | $-0.09 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $-0.02 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $-0.05 | ||
| Q2 24 | $-0.64 | $-0.08 | ||
| Q1 24 | — | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.0M | $6.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $5.9M |
| Total Assets | $82.4M | $44.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $6.2M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | $5.0M | $10.2M | ||
| Q1 25 | — | $11.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | $1.8M | $8.5M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $13.8M | ||
| Q2 24 | — | $13.7M | ||
| Q1 24 | — | $4.4M |
| Q4 25 | — | $5.9M | ||
| Q3 25 | — | $9.0M | ||
| Q2 25 | — | $11.6M | ||
| Q1 25 | — | $14.5M | ||
| Q4 24 | — | $11.1M | ||
| Q3 24 | — | $13.4M | ||
| Q2 24 | — | $17.4M | ||
| Q1 24 | — | $19.6M |
| Q4 25 | — | $44.2M | ||
| Q3 25 | — | $45.8M | ||
| Q2 25 | $82.4M | $48.0M | ||
| Q1 25 | — | $50.8M | ||
| Q4 24 | — | $47.4M | ||
| Q3 24 | — | $47.8M | ||
| Q2 24 | $87.6M | $53.4M | ||
| Q1 24 | — | $47.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.3M | $-4.8M |
| Free Cash FlowOCF − Capex | — | $-4.9M |
| FCF MarginFCF / Revenue | — | -53.4% |
| Capex IntensityCapex / Revenue | — | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-12.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-4.8M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | $-2.3M | $-1.5M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $-2.3M | ||
| Q3 24 | — | $-2.5M | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | — | $-4.9M | ||
| Q3 25 | — | $-2.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $-2.4M | ||
| Q3 24 | — | $-2.6M | ||
| Q2 24 | — | $-4.8M | ||
| Q1 24 | — | $-4.9M |
| Q4 25 | — | -53.4% | ||
| Q3 25 | — | -27.3% | ||
| Q2 25 | — | -16.1% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -30.4% | ||
| Q2 24 | — | -54.4% | ||
| Q1 24 | — | -54.2% |
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.78× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIXI
Segment breakdown not available.
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
